Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
about
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
@en
type
label
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
@en
prefLabel
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
@en
P17
P4844
P921
P1476
Phase 2b Study to Select a Onc ...... l Therapy Naive Adult Subjects
@en
P1813
SIGNET
@en
P3098
NCT01231555
P580
2010-11-18T00:00:00Z
P582
2011-07-04T00:00:00Z